Neuroprotective and Therapeutic Effect of Caffeine on the Rat Model of Parkinson's Disease Induced by Rotenone

References

• Abdin AA, Hamouda HE. Mechanism of the neuroprotective role of coenzyme Q10 with or without L-dopa in rotenone-induced parkinsonism. Neuropharmacology. 2008;55:1340–1346.
   PubMed Web of Science ®Google Scholar
• Aoyama K, Matsumura N, Watabe M, Wang F, Kikuchi-Utsumi K, Nakaki T. Caffeine and uric acid mediate glutathione synthesis for neuroprotection. Neuroscience. 2011;181:206–215.
   PubMed Web of Science ®Google Scholar
• Ascheiro A, Zhang SM, Hernán MA, Kawachi I, Colditz GA, Speizer FE, et al. Prospective study of caffeine consumption and risk of Parkinson's disease in men and women. Annl Neurol. 2001;50:56–63.
   PubMed Web of Science ®Google Scholar
• Banchroft JD, Steven A, Turner DR. Theory and practice of histological technique (4th ed.). New York, NY: Churchil Livingstone. 1996.
   Google Scholar
• Barone P. Neurotransmission in Parkinson's disease: beyond dopamine. Eur J Neurol. 2010;17:364–376.
   PubMed Web of Science ®Google Scholar
• Betarbet R, Sherer TB, MacKenzie G, Garcia-Osuna M, Panov AV, Greenmyre JT. Chronic systemic pesticide exposure reproduces features of Parkinson's disease. Nat Neurobiol. 2000;3:1301–1306.
   Google Scholar
• Beutler E, Duron O, Kelly BM. Improved method for the determination of blood glutathione. J Lab Clin Med. 1963;61:882–888.
   PubMed Web of Science ®Google Scholar
• Bowler K, Tirri R. The temperature characteristics of synaptic membrane ATPases from immature and adult rat brain. J Neurochem. 1974;23:611–613.
   PubMed Web of Science ®Google Scholar
• Braak H, Del Tredici K, Rüb U, de Vos RA, Jansen Steur EN, Braak E. Staging of brain pathology related to sporadic Parkinson's disease. Neurobiol Aging. 2003;24:197–211.
   PubMed Web of Science ®Google Scholar
• Brothers HM, Marchalant Y, Wenk GL. Caffeine attenuates lipopolysaccharide-induced neuroinflammation. Neurosci Lett. 2010;480:97–100.
   PubMed Web of Science ®Google Scholar
• Brown RE, Corey SC, Moore AK. Differences in measures of exploration and fear in MHC-congenic C57BL/6J and B6-H-2K mice. Behav Genetics. 1999;29:263–271.
   Web of Science ®Google Scholar
• Carageorgiou H, Pantos C, Zarros A, Stolakis V, Mourouzis I, Cokkinos D, et al. Changes in acetylcholinesterase, Na+/K+ ATPase, and Mg2+ ATPase activities in the frontal cortex and the hippocampus of hyper and hypothyroid adult rats. Metab Clin Exp. 2007;56:1104–1110.
   PubMed Web of Science ®Google Scholar
• Chen X, Guo C, Kong J. Oxidative stress in neurodegenerative diseases. Neural Regen Res. 2012;7:376–385.
   PubMed Web of Science ®Google Scholar
• Chen JF I, Xu K, Petzer JP, Staal R, Xu YH, Beilstein M, et al. Neuroprotection by caffeine and A(2A) adenosine receptor inactivation in a model of Parkinson's disease. J Neurosci. 2001;21(10):RC143.
   PubMed Web of Science ®Google Scholar
• Choi EY, Jang JY, Cho YO. Coffee intake can promote activity of antioxidant enzymes with increasing MDA level and decreasing HDL-cholesterol in physically trained rats. Nutr Res Pract. 2010;4:283–289.
   PubMed Web of Science ®Google Scholar
• Ciarlone AE. Further modification of a fluoromertric method for analyzing brain amines. Microchem J. 1978;23:9–12.
   Web of Science ®Google Scholar
• Dai SF, Han GZ, Li Y, Yu DQ, Zhang DM, Feng YH, et al. Effects of nicotine on the microglia of Parkinson's disease mice. Asian J Pharmacodyn Pharmacokin. 2008;8:319–323.
   Google Scholar
• Dalmazio I, Santos LS, Lopes RP, Eberlin MN, Augusti R. Advanced oxidation of caffeine in water: on-line and real-time monitoring by electrospray ionization mass spectrometry. Enviro Sci Tech. 2005;39:5982–5988.
   PubMed Web of Science ®Google Scholar
• Dauer W, Przedborski S. Parkinson's disease: mechanisms and models. Neuron. 2003;39:889–909.
   PubMed Web of Science ®Google Scholar
• de Lores Arnaiz GR, Ordieres MG. Brain Na(+), K(+)-ATPase activity in aging and disease. Int J Biomed Sci. 2014;10:85–102.
   PubMedGoogle Scholar
• Demirtaş C, Ofluoğlu E, Hussein A, Paşaoğlu H. Effects of caffeine on oxidant-antioxidant mechanisms in the rat liver. Gazi Med J. 2012;23:13–18.
   Google Scholar
• Dringen R, Pawlowski PJ, Hirrlinger J. Peroxide detoxification by brain cells. J Neurosci Res. 2005;79:157–165.
   PubMed Web of Science ®Google Scholar
• Douglas KT. Mechanism of action of glutathione-dependent enzymes. Adv Enzymol Relat Areas Mol Biol. 1987;59:103–167.
   PubMedGoogle Scholar
• Ellman GL, Courtney KD, Andres V, Featherstone RM. A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem Pharmacol. 1961;7:88–95.
   PubMed Web of Science ®Google Scholar
• Ferre' S, Fuxe K, von Euler G, Johansson B, Fredholm BB. Adenosine-dopamine interactions in the brain. Neuroscience. 1992;51:501–512.
   PubMed Web of Science ®Google Scholar
• Ferre´ S. An update on the mechanisms of the psychostimulant effects of caffeine. J Neurochem. 2008;105:1067–1079.
   PubMed Web of Science ®Google Scholar
• Fisone G, Borgkvist A, Usiello A. Caffeine as a psychomotor stimulant: mechanism of action. Cell Mol Life Sci. 2004;61:857–872.
   PubMed Web of Science ®Google Scholar
• Fleuranceau-More lP, Barrier L, Fauconneau B, Piriou A, Huguet F. Origin of 4-hydroxynonenal incubation-induced inhibition of dopamine transporter and Na/K adenosine triphosphatase in rat striatal synaptosomes. Neurosci Lett. 1999;277:91–94.
   PubMed Web of Science ®Google Scholar
• Fonnum F, Lock EA. The contributions of excitotoxicity, glutathione depletion and DNA repair in chemically induced injury to neurones: exemplified with toxic effects on cerebellar granule cells. J Neurochem. 2004;88:513–531.
   PubMed Web of Science ®Google Scholar
• Giza E, Gotzamani-Psarrakou A, Bostantjopoulou S. Imaging beyond the striatonigral dopaminergic system in Parkinson's disease. Hell J Nucl Med. 2012;15:224–232.
   PubMed Web of Science ®Google Scholar
• Górska AM, Gołembiowska K. The role of adenosine A1 and A2A receptors in the caffeine effect on MDMA-induced DA and 5-HT release in the mouse striatum. Neurotox Res. 2015;27(3):229–245.
   PubMed Web of Science ®Google Scholar
• Gorun V, Proinov I, Baltescu V, Balaban G, Barzu O. Modified Ellman procedure for assay of cholinesterase in crude-enzymatic preparations. Anal Biochem. 1978;86:324–326.
   PubMed Web of Science ®Google Scholar
• Habig WH, Pabst MJ, Jacoby WB. Glutathione-S-transferase; the first step in mercapturic fermentation. J Biochem. 1973;249:7130–7139.
   Google Scholar
• He Y, Imam SZ, Dong Z, Jankovic J, Ali SF, Appel SH, et al. Role of nitric oxide in rotenone-induced nigro-striatal injury. J Neurochem. 2003;86:1338–1345.
   PubMed Web of Science ®Google Scholar
• Hsu CW, Wang CS, Chiu TH. Caffeine and a selective adenosine A2A receptor antagonist induce sensitization and cross-sensitization behavior associated with increased striatal dopamine in mice. J Biomed Sci. 2010;17:4.
   PubMed Web of Science ®Google Scholar
• Imam SZ, Newport GD, Itzhak Y, Cadet JL, Islam F, Slikker Jr W, et al. Peroxynitrite plays a role in methamphetamine- induced dopaminergic neurotoxicity: evidence from mice lacking neuronal nitric oxide synthase gene or overexpressing copper-zinc superoxide dismutase. J Neurochem. 2001;76:745–749.
   PubMed Web of Science ®Google Scholar
• Jomova K, Vondrakova D, Lawson M, Valko M. Metals, oxidative stress and neurodegenerative disorders. Mol Cell Biochem. 2010;345:91–104.
   PubMed Web of Science ®Google Scholar
• Kang CH, Jayasooriya RG, Dilshara MG, Choi YH, Jeong YK, Kim ND, et al. Caffeine suppresses lipopolysaccharide-stimulated BV2 microglial cells by suppressing Akt-mediated NF-κB activation and ERK phosphorylation. Food Chem Toxicol. 2012;50:4270–426.
   PubMed Web of Science ®Google Scholar
• Kiss PJ. Theory of active antidepressants: a nonsynaptic approach to the treatment of depression. Neurochem Int. 2008;52:34–39.
   PubMed Web of Science ®Google Scholar
• Korhonen R, Lahti A, Kankaanranta H, Moilanen E. Nitric oxide production and signaling in inflammation. Curr Drug Targets Inflamm Allergy. 2005;4:471–479.
   PubMedGoogle Scholar
• Kurokawa M, Koga K, Kase H, Nakamura J, Kuwana Y. Adenosine A2A receptor-mediated modulation of striatal acetylcholine release in vivo. J Neurochem. 1996;66:1882–1888.
   PubMed Web of Science ®Google Scholar
• Liu B, Gao HM, Wang JY, Jeohn GH, Cooper CL. Hong JS. Role of nitric oxide in inflammation-mediated neurodegeneration. Ann NY Acad Sci. 2002;962:318–331.
   PubMed Web of Science ®Google Scholar
• Machado-Filho JA, Correia AO, Montenegro AB, Nobre ME, Cerqueira GS, Neves KR, et al. Caffeine neuroprotective effects on 6-OHDA-lesioned rats are mediated by several factors, including pro-inflammatory cytokines and histone deacetylase inhibitions. Behav Brain Res. 2014;264:116–125.
   PubMed Web of Science ®Google Scholar
• Mao X, Chai Y, Lin YF. Dual regulation of the ATP-sensitive potassium channel by caffeine. Am J Physiol Cell Physiol. 2007;292:C2239–C2258.
   PubMed Web of Science ®Google Scholar
• Massaad CA, Klann E. Reactive oxygen species in the regulation of synaptic plasticity and memory. Antioxid Redox Signal. 2011;14:2013–2054.
   PubMed Web of Science ®Google Scholar
• Montgomery HAC, Dymock JF. The determination of nitrite in water. Analyst. 1961;86:414–416.
   Web of Science ®Google Scholar
• Montgomery SL, Bowers WJ. Tumor necrosis factor-alpha and the roles it plays in homeostatic and degenerative processes within the central nervous system. J Neuroimmun Pharmacol. 2012;7:42–59.
   PubMed Web of Science ®Google Scholar
• Nadanasabapathi S, Rufia J, Manju V. Invitro free radical scavenging activity and bioavailability of dietary compounds caffeine, caffeic acid and their combination. Int Food Res J. 2013;20:3159–3165.
   Google Scholar
• Nakaso K, Ito S, Nakashima K. Caffeine activates the PI3K/Akt pathway and prevents apoptotic cell death in a Parkinson's disease model of SH-SY5Y cells. Neurosci Lett. 2008;432:146–150.
   PubMed Web of Science ®Google Scholar
• Nehlig A. Is caffeine a cognitive enhancer? J Alzheimers Dis. 2010;20(Suppl 1):S85–S94.
   PubMedGoogle Scholar
• Nishikimi M, Appaji N, Yogi K. The occurrence of superoxide anion in the reaction of reduced phenazine methosulfate and molecular oxygen. Biochem Biophys Res Common. 1972;46:849–854.
   PubMed Web of Science ®Google Scholar
• Nobre HV Jr, Cunha GMA, Vasconcelos LM, Magalha∼es HIF, Neto RNO, Maia FD, et al. Caffeine and CSC, adenosine A2A antagonists, offer neuroprotection against 6-OHDA-induced neurotoxicity in rat mesencephalic cells. Neurochem Int. 2010;56:51–58.
   PubMed Web of Science ®Google Scholar
• Oakley A. Glutathione transferases: a structural perspective. Drug Metab Rev. 2011 (May);43(2):138–151.
   PubMed Web of Science ®Google Scholar
• Ostrem JL, Galifianakis NB. Overview of common movement disorders. Continuum Lifelong Learn Neurol. 2010;16:13–48.
   Google Scholar
• Petzer A, Pienaar A, Petzer JP. The interactions of caffeine with monoamine oxidase. Life Sci. 2013;93:283–287.
   PubMed Web of Science ®Google Scholar
• Pisani A, Bernardi G, Ding J, Surmeier DJ. Re-emergence of striatal cholinergic interneurons in movement disorders. Trends Neurosci. 2007;30:545–553.
   PubMed Web of Science ®Google Scholar
• Prasanthi JR, Dasari B, Marwarha G, Larson T, Chen X, Geiger JD, et al. Caffeine protects against oxidative stress and Alzheimer's disease-like pathology in rabbit hippocampus induced by cholesterol-enriched diet. Free Radic Biol Med. 2010;49:1212–1220.
   PubMed Web of Science ®Google Scholar
• Rego AC, Oliveira CR. Mitochondrial dysfunction and reactive oxygen species in Excitotoxicity and apoptosis: implications for the pathogenesis of neurodegenerative diseases. Neurochem Res. 2003;28:1563–1574.
   PubMed Web of Science ®Google Scholar
• Ruiz-Larrea MB, Leal AM, Liza M, Lacort M, de Groot H. Antioxidant effects of estradiol and 2-hydroxyestradiol on iron-induced lipid peroxidation of rat liver microsomes. Steroids. 1994;59:383–388.
   PubMed Web of Science ®Google Scholar
• Schapira AH, Olanow CW. Neuroprotection in parkinson disease: mysteries, myths, and misconceptions. JAMA. 2004;291:358–364.
   PubMed Web of Science ®Google Scholar
• Shi X, Dalal NS, Jain AC. Antioxidant behaviour of caffeine: efficient scavenging of hydroxyl radicals. Food Chem Toxicol. 1991;29:1–6.
   PubMed Web of Science ®Google Scholar
• Solinas M, Ferré S, You ZB, Karcz-Kubicha M, Popoli P, Goldberg SR. Caffeine induces dopamine and glutamate release in the shell of the nucleus accumbens. J Neurosci. 2002;22:6321–6324.
   PubMed Web of Science ®Google Scholar
• Souza MA, Mota BC, Gerbatin RR, Rodrigues FS, Castro M, Fighera MR, et al. Antioxidant activity elicited by low dose of caffeine attenuates pentylenetetrazol-induced seizures and oxidative damage in rats. Neurochem Int. 2013;62:821–830.
   PubMed Web of Science ®Google Scholar
• Sun Y, Zhang G, Xu J, Chen S, Tao E, Xu C, et al. Effect of rifampicin pre- and post-treatment on rotenone induced dopaminergic neuronal apoptosis and alpha-synuclein expression. Neural Regen Res. 2010;5:85–91.
   Web of Science ®Google Scholar
• Svenningsson P, Le MoineC, FisoneG, FredholmBB. Distribution, biochemistry and function of striatal adenosine A2A receptors. Prog Neurobiol. 1999;59:355–396.
   PubMed Web of Science ®Google Scholar
• Swathi G, Bhuvaneswar C, Rajendra W. Alterations of cholinergic neurotransmission in rotenone induced parkinson's disease: protective role of bacopa monnieri. Int J Pharm Biol Sci. 2013;3:286–292.
   Google Scholar
• Takakura K, Xiaohong W, Takeuchi K, Fukuda S. Peroxynitrite decreases dopamine's vasoconstrictive activity. Anesth Analg. 2003 (Nov);97(5):1492–6.
   PubMed Web of Science ®Google Scholar
• Tsakiris S, Angelogianni P, Schulpis KH, Behrakis P. Protective effect of l-cysteine and glutathione on rat brain Na+, K+ ATPase inhibition induced by free radicals. Z Naturforsch. 2000a;55:271–277.
   Google Scholar
• Tsakiris S, Angelogianni P, Schulpis KH, Stavridis C. Protective effect of L-phenylalanine on rat brain acetylcholinesterase inhibition induced by free radicals. Clin Biochem. 2000b;33:103–106.
   PubMed Web of Science ®Google Scholar
• Varty GB, Hodgson RA, Pond AJ, Grzelak ME, Parker EM, Hunter JC. The effects of adenosine A2A receptor antagonists on haloperidol-induced movement disorders in primates. Psychopharmacology (Berl). 2008;200:393–401.
   PubMed Web of Science ®Google Scholar
• Watabe M, Nakaki T. Mitochondrial complex I inhibitor rotenone inhibits and redistributes vesicular monoamine transporter 2 via nitration in human dopaminergic SH-SY5Y cells. Mol Pharmacol. 2008;74:933–940.
   PubMed Web of Science ®Google Scholar
• Yu ZF, Kong LD, Chen Y. Antidepressant activity of aqueous extracts of Curcuma longa in mice. J Ethnopharmacol. 2002;83:161–165.
   PubMed Web of Science ®Google Scholar
• Zang LY, Misra HP. Inactivation of acetylcholinesterase by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine hydrochloride. Mol Cell Biochem. 2003;254:131–136.
   PubMed Web of Science ®Google Scholar
• Zhang L, Haraguchi S, Koda T, Hashimoto K, Nakagawara A. Muscle atrophy and motor neuron degeneration in human NEDL1 transgenic mice. J Biomed Biotechnol. 2011;831092. doi:10.1155/2011/831092
   PubMedGoogle Scholar